MEF2C and coronary artery disorder: Xu et al. compared the expression of miRNAs in serum samples from 13 atherosclerotic CAD patients and 5 healthy control subjects and found that circulating miR-499a-3p can inhibit the expression of MEF2C, thereby promoting the proliferation and migration of endothelial cells and smooth muscle cells [21].